SYK and cancer: As a nonreceptor cytoplasmic tyrosine kinase, SYK (spleen tyrosine kinase) is a key mediator in a variety of inflammatory cell and immune signaling pathways and has been proven to be a useful drug target for many cancers (Shinde et al., 2019; Cremer and Stegmaier, 2020; Yang et al., 2020).